Los Angeles Capital Management LLC Sells 3,952 Shares of Encompass Health Corporation $EHC

Los Angeles Capital Management LLC reduced its position in Encompass Health Corporation (NYSE:EHC) by 9.6% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 37,329 shares of the company’s stock after selling 3,952 shares during the quarter. Los Angeles Capital Management LLC’s holdings in Encompass Health were worth $4,578,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. WPG Advisers LLC acquired a new position in Encompass Health in the first quarter valued at $27,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of Encompass Health by 749.0% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock valued at $42,000 after purchasing an additional 367 shares in the last quarter. Park Place Capital Corp acquired a new stake in Encompass Health during the second quarter worth approximately $72,000. Caitong International Asset Management Co. Ltd increased its holdings in Encompass Health by 19.0% in the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after purchasing an additional 115 shares in the last quarter. Finally, SVB Wealth LLC acquired a new position in Encompass Health in the first quarter valued at approximately $84,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have recently commented on EHC shares. Barclays raised their price objective on shares of Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a research report on Thursday, October 30th. Bank of America lifted their price target on shares of Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a research note on Wednesday, September 10th. UBS Group increased their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Thursday, October 2nd. KeyCorp raised their target price on Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a research note on Tuesday, September 16th. Finally, Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. Three equities research analysts have rated the stock with a Strong Buy rating and eight have given a Buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $142.86.

Encompass Health Trading Up 0.1%

NYSE:EHC opened at $115.18 on Monday. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. Encompass Health Corporation has a one year low of $87.85 and a one year high of $127.99. The company has a market cap of $11.59 billion, a PE ratio of 21.77, a PEG ratio of 2.20 and a beta of 0.91. The firm has a 50-day moving average of $123.54 and a 200-day moving average of $119.64.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. The business had revenue of $136.30 million during the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. As a group, equities research analysts expect that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a dividend of $0.19 per share. The ex-dividend date is Friday, January 2nd. This represents a $0.76 annualized dividend and a yield of 0.7%. Encompass Health’s dividend payout ratio is 14.37%.

Insider Buying and Selling

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the firm’s stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the transaction, the executive vice president directly owned 18,846 shares in the company, valued at approximately $2,329,177.14. This trade represents a 5.13% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.00% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.